Jonathan J. Keats

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Mutational signatures as potential predictors of HIPEC response and recurrence in ovarian cancer.

  Journal of Clinical Oncology · 2026-05-28

• Alternative splicing signatures to predict response from hyperthermic intra-peritoneal chemotherapy (HIPEC) treatment in ovarian cancer patients.

  Journal of Clinical Oncology · 2026-05-28

• Abstract 2495: Rapid clinical diagnostic classification and risk stratification in acute myelogenous leukemia (AML) using whole genome sequencing (WGS)

  Cancer Research · 2026-04-03

• Abstract 3887: Multiple myeloma risk classification of CoMMpass using Consensus Genomic Staging identifies differences between patients with high and low African genetic ancestry.

  Cancer Research · 2026-04-03

• Supplemental Figure 4 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 5 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 25 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 11 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 8 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 22 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 18 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 23 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 16 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 2 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 19 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 10 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 13 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 24 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 3 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04

• Supplemental Figure 1 from Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

  2026-03-04